Digital PCR (dPCR) and Real-time PCR (qPCR) Market – By Product & Services (Instruments, Reagents & Consumables, and Software & Services), By Application (Clinical, Research, and Forensics), By End-User (Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories), and By Region-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 – 2029

                                          
Abstract
                    
This report analyzes and estimates the Digital PCR (dPCR) and Real-time PCR (qPCR) market at global, regional, and country level. The research study provides historic data from 2015 to 2019 along with forecast from 2020 to 2025 based on value (USD Million). The report offers detailed insights of the Digital PCR (dPCR) and Real-time PCR (qPCR) market drivers and restraints along with their impact analysis at global level from 2015 to 2025.

The report covers in-depth analysis of the strategies adopted by major competitors in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market. To understand the competitive landscape in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market, an analysis of Porter’s Five Forces model is also included. The research study comprises of market attractiveness analysis, wherein all the segments are benchmarked on the basis of their market size and growth rate.


The research study provides a decisive view on the global Digital PCR (dPCR) and Real-time PCR (qPCR) market based on Source, Packaging Process, Raw Material, End-Use, and Region. All the segments of the market have been analyzed based on the past, present, and future trends. The market is estimated from 2019 to 2025.

The nonstop technological innovations in PCR tools and increasing prevalence of target genetic disorders & infectious diseases are the primary factors anticipated to bolster the global Digital PCR (dPCR) and Real-time PCR (qPCR) market during the forecast period. Additionally, the increasing grants, investments, and funds will further help the market propel in the coming years. The mounting application of biomarker profiling for ailment diagnostics and efficacious accomplishment of the Human Genome Project is expected to fuel the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) market. The growing advancements in the R&D activities are projected to surge the demand for innovative Digital PCR (dPCR) and Real-time PCR (qPCR) techniques.

The proven effectiveness of dPCR and qPCR analysis in the estimation and diagnosis of disease-causing microbes will escalate the application of clinical diagnostic tests such as qPCR and dPCR analysis, thereby augmenting the market growth.  The high costs of the instruments, especially dPCR, and the technical limitations of PCR are likely to restrain the market growth. Furthermore, the large capital investments and intricate scientific validation on a nanoscale level during the development of qPCR and dPCR instruments coupled with the demand for specific reagents depending on the end-use will hamper the Digital PCR (dPCR) and Real-time PCR (qPCR) market growth.

On the basis of product & services, the global Digital PCR (dPCR) and Real-time PCR (qPCR) market is divided into Instruments, Reagents & Consumables, and Software & Services. Based on application, the market for Digital PCR (dPCR) and Real-time PCR (qPCR) is segregated into Clinical, Research, and Forensics. In terms of end-user, the market is categorized into Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories. The regional segmentation comprises the past, present, and estimated demand for the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. The regional segment is further split into the U.S., Canada, Mexico, UK, France, Germany, China, Japan, India, South Korea, Brazil, and Argentina among others.

Some of the key players in the global Digital PCR (dPCR) and Real-time PCR (qPCR) market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., and QIAGEN N.V.

The report categorizes the global Digital PCR (dPCR) and Real-time PCR (qPCR) market into:

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: By Products & Services Segmentation Analysis

	Instruments
	Reagents & Consumables
	Software & Services

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: By Application Segmentation Analysis

	
	Clinical

	
		Infectious Diseases Testing
		Oncology Testing
		Blood Screening
		Transplant Diagnostics
		Others
	
	
	Research
	Forensic

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: By End-User Segmentation Analysis

	Hospitals and Diagnostic Centers
	Research Laboratories and Academic Institutes
	Pharmaceutical and Biotechnology Companies
	Clinical Research Organizations
	Forensic Laboratories

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: By Regional Segmentation Analysis

	North America
	
		The U.S.
		Canada
	
	
	Europe
	
		France
		The UK
		Spain
		Germany
		Italy
		Rest of Europe
	
	
	Asia Pacific
	
		China
		Japan
		India
		South Korea
		Southeast Asia
		Rest of Asia Pacific
	
	
	Latin America
	
		Brazil
		Mexico
		Rest of Latin America
	
	
	Middle East & Africa
	
		GCC
		South Africa
		Rest of Middle East & Africa